Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 4:05 pm Purchase | 2025-04-03 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Commodore Capital LP | 3,350,000 5.000% | 3,350,000 (New Position) | Filing History |
| 2025-02-25 4:05 pm Purchase | 2025-02-18 | 13G | SOLID BIOSCIENCES INC SLDB | Commodore Capital LP | 5,825,000 7.600% | 5,825,000 (New Position) | Filing History |
| 2025-02-14 5:20 pm Unchanged | 2024-12-31 | 13G | NKARTA INC NKTX | Commodore Capital LP | 351,848 0.500% | 0 (Unchanged) | Filing History |
| 2025-02-14 5:14 pm Unchanged | 2024-12-31 | 13G | CELCUITY INC CELC | Commodore Capital LP | 1,095,650 2.900% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:05 pm Sale | 2024-12-31 | 13G | NKARTA INC NKTX | Commodore Capital LP | 351,848 0.500% | -148,152 (-29.63%) | Filing History |
| 2025-02-14 4:05 pm Sale | 2024-12-31 | 13G | CELCUITY INC CELC | Commodore Capital LP | 1,095,650 2.900% | -1,122,332 (-50.60%) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Commodore Capital LP | 500,000 7.200% | 100,000 (+25.00%) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2025-02-07 | 13G | NURIX THERAPEUTICS INC NRIX | Commodore Capital LP | 3,850,000 5.100% | 3,850,000 (New Position) | Filing History |
| 2024-12-17 4:06 pm Purchase | 2024-12-10 | 13G | CARDIFF ONCOLOGY INC CRDF | Commodore Capital LP | 5,384,616 8.100% | 5,384,616 (New Position) | Filing History |
| 2024-12-16 9:51 pm Purchase | 2024-12-09 | 13G | MERUS N V COM MRUS | Commodore Capital LP | 3,750,000 5.500% | 400,000 (+11.94%) | Filing History |
| 2024-12-11 4:05 pm Purchase | 2024-12-04 | 13G | NEUROGENE INC NGNE | Commodore Capital LP | 800,000 5.400% | 800,000 (New Position) | Filing History |
| 2024-11-14 4:10 pm Sale | 2024-09-30 | 13G | VERA THERAPEUTICS INC VERA | Commodore Capital LP | 2,475,000 4.500% | -1,425,000 (-36.54%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | MERUS N V COM MRUS | Commodore Capital LP | 3,350,000 4.900% | -1,397,373 (-29.43%) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Commodore Capital LP | 4,100,000 8.700% | 1,198,184 (+41.29%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-02-29 | 13G | VERA THERAPEUTICS INC VERA | Commodore Capital LP | 3,900,000 7.300% | -1,550,000 (-28.44%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | C4 THERAPEUTICS INC CCCC | Commodore Capital LP | 3,410,384 4.800% | -389,616 (-10.25%) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | MIND MEDICINE MINDMED INC MNMD | Commodore Capital LP | 8,176,721 9.900% | 2,343,388 (+40.17%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | CELCUITY INC CELC | Commodore Capital LP | 2,217,982 5.900% | -274,904 (-11.03%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Commodore Capital LP | 3,350,000 4.960% | -540,667 (-13.90%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Commodore Capital LP | 0 0.000% | -1,000,000 (Position Closed) | Filing History |